Pharmacology and Physiology
The Doctoral Programme in Pharmacology and Physiology seeks to train independent researchers and provide a professional research qualification in the field of Pharmacology and Physiology.
This Programme is particularly focused in training researchers in two main areas with high social and health impact, such are Cardiovascular Pharmacology and Neuropsychopharmacology. Cardiovascular events (i.e., myocardial infarction, stroke) are nowadays a main cause of death worldwide and they are very closely related to diseases like hypertension, atherosclerosis, or the cardiometabolic complications of obesity and diabetes mellitus. On the other hand, the accelerated ageing of the population in Western countries is accompanied by a higher prevalence of diseases such as vascular dementia, and neurodegenerative diseases, including Alzheimer’s disease.
Overall, our research Programme seeks to understand the basis of diseases, at different organizational levels, including molecular, cellular, ex vivo, in vivo, and patient-based translational approaches. The ultimate aim is to identify therapeutic targets that may be modulated by drugs for disease prevention, delay or treatment.
Research lines
- Cardiovascular and Renal Pharmacology
- Psyconeuropharmacology
- Clinical Pharmacology
Members of the Academic Committee
Degree Official Documentation
- Verification Memory
- Verification Resolution
- Accreditation renewal resolution
- Link to the registry of Universities, Centers and Degrees
Monitoring and Quality
Members of the Quality Assurance Commission
|
Facts & Figures
